Melbourne-based biotech firm PolyActiva, which has spent 15 years developing an eye-implant technology to treat glaucoma, has won a $27 million investment from the National Reconstruction Fund Corporation as...
The corporation managing the government’s $15 billion industry fund has agreed to review potential risks to the Commonwealth from its $32 million equity investment in a startup linked to...
Career banker David Gall has been handed the reins of the agency responsible for the federal government’s $15 billion manufacturing fund, arriving as its first investments roll out to...